Understanding GLP1 Medications and Their Importance GLP1 medications, or glucagon-like peptide-1 receptor agonists, have become a significant advancement in the treatment of type 2 diabetes and obesity
Losing significant amounts of body fat can alter hormone levels, particularly estrogen
These agents, which have shown efficacy in non-transplant populations, present new opportunities for improving the management of diabetes mellitus in liver transplant recipients, potentially mitigating the adverse effects of PTDM and enhancing long-term outcomes
Although semaglutide is under patent by Novo Nordisk, the company behind Ozempic and Wegovy, compounding is entirely legal and even encouraged by the FDA
MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer